This is a Validated Antibody Database (VAD) review about human 15 hydroxyprostaglandin dehydrogenase, based on 2 published articles (read how Labome selects the articles), using 15 hydroxyprostaglandin dehydrogenase antibody in all methods. It is aimed to help Labome visitors find the most suited 15 hydroxyprostaglandin dehydrogenase antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
15 hydroxyprostaglandin dehydrogenase synonym: 15-PGDH; PGDH; PGDH1; PHOAR1; SDR36C1; 15-hydroxyprostaglandin dehydrogenase [NAD(+)]; 15-hydroxyprostaglandin dehydrogenase (NAD(+)); NAD+-dependent 15-hydroxyprostaglandin dehydrogenase; hydroxyprostaglandin dehydrogenase 15-(NAD); prostaglandin dehydrogenase 1; short chain dehydrogenase/reductase family 36C member 1

Santa Cruz Biotechnology
mouse monoclonal (H-3)
  • immunohistochemistry - frozen section; human; loading ...; fig 4a
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology 15 hydroxyprostaglandin dehydrogenase antibody (Santa Cruz Biotechnology, H-3) was used in immunohistochemistry - frozen section on human samples (fig 4a) and in western blot on human samples (fig 3a). BMC Cancer (2019) ncbi
Abcam
rabbit monoclonal (EPR14332-19)
  • immunohistochemistry - paraffin section; human; fig 1c
  • western blot; human; fig 2a
Abcam 15 hydroxyprostaglandin dehydrogenase antibody (Abcam, ab187161) was used in immunohistochemistry - paraffin section on human samples (fig 1c) and in western blot on human samples (fig 2a). Cancer Sci (2018) ncbi
Articles Reviewed
  1. Petersen C, Mahmood B, Badsted C, Dahlby T, Rasmussen H, Hansen M, et al. Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia. BMC Cancer. 2019;19:643 pubmed publisher
  2. Arima K, Komohara Y, Bu L, Tsukamoto M, Itoyama R, Miyake K, et al. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer. Cancer Sci. 2018;109:462-470 pubmed publisher